Print Page
Download PDFWound Management & Surgical Reconstruction (WMSR)
LifeNet Health’s portfolio of allografts offers the most advanced solutions for healing, from soft tissue reconstruction to chronic wounds.
Dermacell AWM® is a human acellular dermal matrix (ADM) that serves as a scaffold to reinforce damaged or inadequate soft tissue at the surgical site. Using LifeNet Health’s proprietary and validated Matracell® decellularization technology, epidermal and dermal cells are removed, while preserving the extracellular matrix (ECM) that aid and are vital in the healing cascade.
Matrion™ is a human placental allograft used as a barrier membrane to treat chronic and acute wounds. Matrion is the first naturally intact placental membrane to incorporate the full trophoblast layer, combined with decellularization using Matracell technology.
ReadiGraft® CryoSkin is cryopreserved human skin composed of frozen fibroblasts and keratinocytes and a fully developed extracellular matrix (ECM) in its epidermal and dermal layers. Cryopreserved human skin provides a biological wound dressing for acute burn injuries.
Wound Management & Surgical Reconstruction (WMSR)
- Handling: Matrion’s inclusion of the amnion, chorion and trophoblast layers results in a graft that is up to four times thicker than the Amniotic and Chorionic membranes.1
- Convenience: No need to rehydrate, thaw or otherwise prepare prior to application.
- Safety: Up to four times thicker than traditional bilayer grafts, Matrion provides a more substantial barrier, preventing fluid loss as well as bacterial ingress.2
- Sterility: Sterilized to a Sterility Assurance Level (SAL) of 10-6, medical device grade sterility.3
- Growth Factor Retention: Matrion retains more endogenous growth factors than other placental membranes that lack the full trophoblast layer.4 Analyses have demonstrated that the trophoblast layer accounts for more than 50% of the total amount of key biological factors in placental tissue.5
References
- Biohospitable: Cells and ≥ 97% donor DNA removed to potentially minimize any adverse patient response
- Intact Acellular Framework: Retains native growth factors, collagen and elastin
- Room Temperature Storage: Ready to use out of the package
- Strength: Pull-out strength and load to failure are comparable to native dermis
- Sterile: Sterilized to a Sterility Assurance Level (SAL) of 10-6, medical device-grade sterility
- Structural Support: Facilitates use with sutures, staples
- Proven: Conducted the largest randomized controlled trial (RCT) to date using hADM in chronic wounds.1
1. Cazzell, S., Vayser, D., Pham H., et al. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator. Wound Repair and Regeneration. 2017.
Chronic Wounds* – Diabetic foot ulcers (DFUs), venous stasis ulcers (VSUs), arterial ulcers, pressure ulcers, dehisced surgical wounds, traumatic burns
* Dermacell AWM can be used over exposed tendon, bone, joint capsule, and muscle
| Order Code | Description | Size |
|---|---|---|
| DCELL100 | Unmeshed | 2 x 2 cm (0.2 - 1 mm thickness) |
| DCELL101 | Unmeshed | 4 x 4 cm (0.2 - 1 mm thickness) |
| DCELL102 | Unmeshed | 5 x 7 cm (0.2 - 1 mm thickness) |
| DCELL103 | Unmeshed | 6 x 7 cm (0.2 - 1 mm thickness) |
| DCELL104 | Unmeshed | 4 x 8 cm (0.2 - 1 mm thickness) |
| DCELL110 | Meshed | 2 x 2 cm (0.2 - 1 mm thickness) |
| DCELL111 | Meshed | 3 x 3 cm (0.2 - 1 mm thickness) |
| DCELL112 | Meshed | 4 x 4 cm (0.2 - 1 mm thickness) |
| DCELL152 | Meshed | 5 x 7 cm (0.2 - 1 mm thickness) |
| DCELL153 | Meshed | 6 x 7 cm (0.2 - 1 mm thickness) |
| DCELL154 | Meshed | 4 x 8 cm (0.2 - 1 mm thickness) |
| DCELL155 | Meshed | 5 x 9 cm (0.2 - 1 mm thickness) |
| DCELL156 | Meshed | 4 x 10 cm (0.2 - 1 mm thickness) |
| DCELL157 | Meshed | 6 x 10 cm (0.2 - 1 mm thickness) |
| DCELL158 | Meshed | 8 x 10 cm (0.2 - 1 mm thickness) |
| DCELL159 | Meshed | 8 x 12 cm (0.2 - 1 mm thickness) |
Dermacell is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented and validated processing technology. Matracell removes a minimum of 97% of donor DNA, allowing for rapid cellular infiltration and re-vascularization. Dermacell is terminally sterilized, ready to use without refrigeration or re-hydration.
- Biohospitable: Cells and ≥ 97% DNA removed to minimize any adverse patient response
- Intact Acellular Framework: Retains native growth factors, collagen and elastin
- Room Temperature Storage: Ready to use out of the package via patented Preservon technology
- Strength: Pull-out strength and load to failure are comparable to existing allograft products
- Sterile: Sterilized to a Sterility Assurance Level (SAL) of 10-6, medical device-grade sterility
- Soft Tissue Reconstruction
| Room Temperature | Description | Size |
|---|---|---|
| DCELL200 | Unmeshed | 4 x 12 cm (0.75 - 1.5 mm thickness) |
| DCELL201 | Unmeshed | 6 x 12 cm (0.75 - 1.5 mm thickness) |
| DCELL202 | Unmeshed | 4 x 16 cm (0.75 - 1.5 mm thickness) |
| DCELL203 | Unmeshed | 5 x 16 cm (0.75 - 1.5 mm thickness) |
| DCELL204 | Unmeshed | 6 x 16 cm (0.75 - 1.5 mm thickness) |
| DCELL205 | Unmeshed | 8 x 16 cm (0.75 - 1.5 mm thickness) |
| DCELL206 | Unmeshed | 8 x 20 cm (0.75 - 1.5 mm thickness) |
| DCELL207 | Unmeshed | 16 x 20 cm (0.75 - 1.5 mm thickness) |
| DCELL208 | Unmeshed | 20 x 20 cm (0.75 - 1.5 mm thickness) |
| DCELL209 | Unmeshed | 20 x 25 cm (0.75 - 1.5 mm thickness) |
| DCELL250 | Unmeshed | 4 x 12 cm (1.25 - 2 mm thickness) |
| DCELL251 | Unmeshed | 6 x 12 cm (1.25 - 2 mm thickness) |
| DCELL252 | Unmeshed | 4 x 16 cm (1.25 - 2 mm thickness) |
| DCELL253 | Unmeshed | 5 x 16 cm (1.25 - 2 mm thickness) |
| DCELL254 | Unmeshed | 6 x 16 cm (1.25 - 2 mm thickness) |
| DCELL255 | Unmeshed | 8 x 16 cm (1.25 - 2 mm thickness) |
| DCELL256 | Unmeshed | 8 x 20 cm (1.25 - 2 mm thickness) |
| DCELL257 | Unmeshed | 16 x 20 cm (1.25 - 2 mm thickness) |
| DCELL258 | Unmeshed | 20 x 20 cm (1.25 - 2 mm thickness) |
| DCELL259 | Unmeshed | 20 x 25 cm (1.25 - 2 mm thickness) |
| DCELL217M | Microperforated | 16 x 20 cm (0.6 - 1.05 mm thickness) |
| DCELL216M | Microperforated | 8 x 20 cm (0.6 - 1.05 mm thickness) |
| DCELL216 | Unmeshed | 8 x 20 cm (0.6 - 1.05 mm thickness) |
| DCELL215M | Microperforated | 8 x 16 cm (0.6 - 1.05 mm thickness) |
| DCELL214 | Unmeshed | 6 x 16 cm (0.6 - 1.05 mm thickness) |
| DCELL214M | Microperforated | 6 x 16 cm (0.6 - 1.05 mm thickness) |
| DCELL215 | Unmeshed | 8 x 16 cm (0.6 - 1.05 mm thickness) |
- Biological barrier to minimize the threat of bacterial or fungal contamination
- Thermoregulation
- Capacity for regeneration and healing in the recipient
- Adherence
- Elasticity
- Long shelf life
- Minimal prep time
- Biological dressing for traumatic burn injuries
- 2nd & 3rd degree burns
- Cosmetic reconstruction after traumatic burn injuries
| Frozen | Description | Size |
|---|---|---|
| SK NM | Meshed | 1/8 sq ft or 125 cm² (1.5:1) |
| SK F | Meshed | 1/6 sq ft or 154 cm² (1.5:1) |
| SK M | Meshed | 1/4 sq ft or 232 cm² (1.5:1) |
| SK Z | Meshed | 1/4 sq ft or 232 cm² (2:1) |
| SK HM | Meshed | 1/2 sq ft or 500 cm² (1.5:1) |
| SK B | Unmeshed | 16 sq cm² |
| SK N | Unmeshed | 1/8 sq ft or 125 cm² |
| SK S | Unmeshed | 1/6 sq ft or 154 cm² |
| SK P | Unmeshed | 1/4 sq ft or 232 cm² |
| SK H | Unmeshed | 1/2 sq ft or 500 cm² |
Dermacell AWM Reimbursement Tools
Information regarding Dermacell AWM reimbursement is available in the following guides:
- Reimbursement Resource Guide
- Outpatient Facitlity and ASC Coding and Payment Guide
- Physician Office Payment Guide
- In-Patient Billing Guide
- ICD-10 Guide
For additional information regarding wound reimbursement, please call the Pre-Authorization and Coding Hot-Line at 866-562-6349 or email dermacell@mcra.com.
Matrion Reimbursement Tools
Information regarding Matrion reimbursement is available in the following guides: